CAS: 1391737-01-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | VU 0463271 REF: IN-DA01ENNUCAS: 1391737-01-1 | 98% | To inquire | Tue 10 Dec 24 |
 | VU 0463271 REF: TR-V797690CAS: 1391737-01-1 | - - - | 5,367.00 € | Tue 21 Jan 25 |
 | VU0463271 REF: 3D-RFC73701CAS: 1391737-01-1 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | VU0463271 REF: TM-T17243CAS: 1391737-01-1 | 99.75% | 36.00 €~504.00 € | Mon 10 Feb 25 |
VU 0463271
CAS:1391737-01-1
Formula:
C19H18N4OS2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
382.5024
Ref: IN-DA01ENNU
| 5mg | 156.00 € | ||
| 10mg | 242.00 € | ||
| 25mg | 547.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
VU 0463271
Controlled ProductCAS:1391737-01-1
Formula:
C19H18N4OS2
Color and Shape:
Neat
Molecular weight:
382.502
Ref: TR-V797690
| 250mg | 5,367.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
VU0463271
CAS:1391737-01-1
VU0463271 is a benzodiazepine receptor ligand that has been shown to inhibit neuronal function in …
Formula:
C19H18N4OS2
Purity:
Min. 95%
Molecular weight:
382.5 g/mol
Ref: 3D-RFC73701
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
VU0463271
CAS:1391737-01-1
VU0463271: KCC2 antagonist, IC50 61 nM, >100x selective over NKCC1, inactive on other GPCRs, channels, …
Formula:
C19H18N4OS2
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
382.5
Ref: TM-T17243
| 5mg | 49.00 € | ||
| 10mg | 77.00 € | ||
| 25mg | 154.00 € | ||
| 50mg | 240.00 € | ||
| 100mg | 354.00 € | ||
| 200mg | 504.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
